Market Overview

SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of MGC Diagnostics Corporation and Encourages Investors to Contact the Firm for Additional Information

Share:

The securities litigation law firm of Brower Piven, A Professional
Corporation, has commenced an investigation into possible breaches of
fiduciary duty and other violations of state law by the Board of
Directors of MGC Diagnostics Corporation (Nasdaq: MGCD) ("MGC
Diagnostics" or the "Company") relating to the proposed buyout of MGC
Diagnostics by Altus Capital Partners, Inc.

Under the terms of the agreement, MGC Diagnostics shareholders are
anticipated to receive $11.03 in cash for each share of MGC Diagnostics
common stock held. The firm's investigation seeks to determine, among
other things, whether the Company's Board of Directors failed to satisfy
their duties to shareholders, including whether the Board adequately
pursued alternatives to the acquisition and whether the Board obtained
the best price possible for the Company's shares of common stock.

If you currently own common stock of MGC Diagnostics and believe that
the proposed buyout price is too low, and you would like to learn more
about the investigation being conducted by Brower Piven, please visit
our website at http://www.browerpiven.com/casesandinvestigations.html.
You may also request additional information by contacting Brower Piven
either by email at hoffman@browerpiven.com
or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating
securities and other class action cases and have been advocating for the
rights of shareholders since the 1980s.

View Comments and Join the Discussion!
 
Lightning Fast
Market News Service
$199 Free 14 Day Trial